Question 1

How does Parietaria officinalis work for kidney stones?

Accepted Answer

Parietaria officinalis works through multiple mechanisms to support kidney and urinary tract health. Its flavonoid content provides anti-inflammatory effects, while mucilage compounds offer demulcent properties that soothe irritated urinary tract tissues. The herb contains nitrate salts that promote diuretic action, increasing urine volume and potentially helping flush small calculi. Traditional use suggests it may help prevent stone formation, though clinical evidence remains limited (Evidence Level C). The combination of increased diuresis and tissue-soothing effects makes it a traditional choice for kidney stone management.

Question 2

Does Parietaria interact with any medications?

Accepted Answer

Parietaria officinalis has limited documented drug interaction data. Due to its diuretic properties, it may theoretically enhance the effects of prescription diuretic medications such as furosemide or hydrochlorothiazide, potentially causing electrolyte imbalances. Patients taking lithium should exercise caution, as increased diuresis may affect lithium clearance and blood levels. Those on antihypertensive medications should monitor blood pressure closely, as the herb's diuretic action may potentiate hypotensive effects. Always consult a healthcare provider before combining herbal remedies with prescription medications.

Question 3

What is the recommended dosage for Parietaria?

Accepted Answer

The traditional adult dosage for Parietaria officinalis is 4-6 grams of fresh herb or 2-3 grams of dried herb prepared as a tea, taken three times daily. To prepare, steep the herb in boiling water for 10-15 minutes before straining. For kidney stone prevention or urinary tract support, this dosage may be continued for several weeks under professional guidance. Evidence for optimal dosing is limited (Evidence Level C), based primarily on traditional use rather than clinical trials. Individual needs may vary based on the condition being addressed.

Question 4

Is Parietaria safe during pregnancy and breastfeeding?

Accepted Answer

Parietaria officinalis is not considered safe during pregnancy and should be avoided. The herb's diuretic properties may alter fluid and electrolyte balance, potentially affecting fetal development. Additionally, its traditional use for stimulating urinary function raises theoretical concerns about uterine effects. There is insufficient safety data for breastfeeding, so avoidance is recommended. Women who are pregnant, trying to conceive, or nursing should consult a qualified healthcare provider before using any herbal preparations. The potential risks outweigh any theoretical benefits during these life stages.

Question 5

What are the side effects and allergy risks of Parietaria?

Accepted Answer

Parietaria officinalis carries notable allergy risks due to its highly allergenic pollen. Individuals with pollen allergies, particularly those sensitive to wall pellitory pollen, may experience allergic reactions including skin rashes, respiratory symptoms, or contact dermatitis. There is documented cross-reactivity with latex allergy, so individuals with latex sensitivity should avoid this herb entirely. Other potential side effects include mild diuresis, which may cause increased urination frequency. Discontinue use immediately if any allergic symptoms develop. Those with known plant allergies should exercise particular caution.

Question 6

What is Parietaria used for in herbal medicine?

Accepted Answer

Parietaria officinalis, also known as pellitory-of-the-wall, has been used traditionally as a kidney tonic and urinary tract remedy. Historical applications include dissolving urinary calculi (kidney stones and gravel), treating cystitis and urinary infections, and addressing dropsy and edema through its diuretic action. As one of the traditional Nine Sacred Herbs of European medicine, it was valued for urinary demulcent properties that soothe irritated tissues. Modern herbalists continue to recommend it for kidney stone prevention and urinary tract support, though clinical evidence remains limited (Evidence Level C).

Parietaria

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales